Report Detail
Global Recombinant Human Erythropoietin for Injection Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
- RnM4570629 |
- 08 December, 2023 |
- Global |
- 113 Pages |
- GIR (Global Info Research) |
- Pharma & Healthcare
According to our (Global Info Research) latest study, the global Recombinant Human Erythropoietin for Injection market size was valued at USD 9433.4 million in 2022 and is forecast to a readjusted size of USD 14120 million by 2029 with a CAGR of 5.9% during review period.
Erythropoietin is produced by interstitial fibroblasts in the kidney in close association with peritubular capillary and proximal convoluted tubule. It is also produced in perisinusoidal cells in the liver. While liver production predominates in the fetal and perinatal period, renal production is predominant during adulthood.
Recombinant Human Erythropoietin for Injection is a crucial biopharmaceutical product used in the treatment of anemia, with a substantial and continually growing market size. The ongoing aging of the population and the rise in chronic disease patients have maintained a steady demand for erythropoietin. Furthermore, the continuous advancement in biopharmaceutical technology is expected to enhance product efficacy and convenience, expanding potential market applications, including the treatment of kidney disease and cancer patients, offering more opportunities for future development.
The Global Info Research report includes an overview of the development of the Recombinant Human Erythropoietin for Injection industry chain, the market status of Anemia (Epoetin-alfa, Epoetin-beta), Kidney Disorders (Epoetin-alfa, Epoetin-beta), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Recombinant Human Erythropoietin for Injection.
Regionally, the report analyzes the Recombinant Human Erythropoietin for Injection markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Recombinant Human Erythropoietin for Injection market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Recombinant Human Erythropoietin for Injection market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Recombinant Human Erythropoietin for Injection industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Epoetin-alfa, Epoetin-beta).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Recombinant Human Erythropoietin for Injection market.
Regional Analysis: The report involves examining the Recombinant Human Erythropoietin for Injection market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Recombinant Human Erythropoietin for Injection market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Recombinant Human Erythropoietin for Injection:
Company Analysis: Report covers individual Recombinant Human Erythropoietin for Injection manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Recombinant Human Erythropoietin for Injection This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Anemia, Kidney Disorders).
Technology Analysis: Report covers specific technologies relevant to Recombinant Human Erythropoietin for Injection. It assesses the current state, advancements, and potential future developments in Recombinant Human Erythropoietin for Injection areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Recombinant Human Erythropoietin for Injection market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Recombinant Human Erythropoietin for Injection market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Epoetin-alfa
Epoetin-beta
Darbepoetin-alfa
Others
Market segment by Application
Anemia
Kidney Disorders
Others
Major players covered
Amgen
Johnson & Johnson
Roche
Kyowa Kirin
LG Chem
Daewoong Pharmaceutical
Wockhardt
CJ Healthcare
3SBio
Kexing Biopharm
Harbin Pharmaceutical Group
Beijing Four Rings Bio-Pharmaceutical
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Recombinant Human Erythropoietin for Injection product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Recombinant Human Erythropoietin for Injection, with price, sales, revenue and global market share of Recombinant Human Erythropoietin for Injection from 2018 to 2023.
Chapter 3, the Recombinant Human Erythropoietin for Injection competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Recombinant Human Erythropoietin for Injection breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Recombinant Human Erythropoietin for Injection market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Recombinant Human Erythropoietin for Injection.
Chapter 14 and 15, to describe Recombinant Human Erythropoietin for Injection sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope of Recombinant Human Erythropoietin for Injection
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Recombinant Human Erythropoietin for Injection Consumption Value by Type: 2018 Versus 2022 Versus 2029
- 1.3.2 Epoetin-alfa
- 1.3.3 Epoetin-beta
- 1.3.4 Darbepoetin-alfa
- 1.3.5 Others
- 1.4 Market Analysis by Application
- 1.4.1 Overview: Global Recombinant Human Erythropoietin for Injection Consumption Value by Application: 2018 Versus 2022 Versus 2029
- 1.4.2 Anemia
- 1.4.3 Kidney Disorders
- 1.4.4 Others
- 1.5 Global Recombinant Human Erythropoietin for Injection Market Size & Forecast
- 1.5.1 Global Recombinant Human Erythropoietin for Injection Consumption Value (2018 & 2022 & 2029)
- 1.5.2 Global Recombinant Human Erythropoietin for Injection Sales Quantity (2018-2029)
- 1.5.3 Global Recombinant Human Erythropoietin for Injection Average Price (2018-2029)
2 Manufacturers Profiles
- 2.1 Amgen
- 2.1.1 Amgen Details
- 2.1.2 Amgen Major Business
- 2.1.3 Amgen Recombinant Human Erythropoietin for Injection Product and Services
- 2.1.4 Amgen Recombinant Human Erythropoietin for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.1.5 Amgen Recent Developments/Updates
- 2.2 Johnson & Johnson
- 2.2.1 Johnson & Johnson Details
- 2.2.2 Johnson & Johnson Major Business
- 2.2.3 Johnson & Johnson Recombinant Human Erythropoietin for Injection Product and Services
- 2.2.4 Johnson & Johnson Recombinant Human Erythropoietin for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.2.5 Johnson & Johnson Recent Developments/Updates
- 2.3 Roche
- 2.3.1 Roche Details
- 2.3.2 Roche Major Business
- 2.3.3 Roche Recombinant Human Erythropoietin for Injection Product and Services
- 2.3.4 Roche Recombinant Human Erythropoietin for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.3.5 Roche Recent Developments/Updates
- 2.4 Kyowa Kirin
- 2.4.1 Kyowa Kirin Details
- 2.4.2 Kyowa Kirin Major Business
- 2.4.3 Kyowa Kirin Recombinant Human Erythropoietin for Injection Product and Services
- 2.4.4 Kyowa Kirin Recombinant Human Erythropoietin for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.4.5 Kyowa Kirin Recent Developments/Updates
- 2.5 LG Chem
- 2.5.1 LG Chem Details
- 2.5.2 LG Chem Major Business
- 2.5.3 LG Chem Recombinant Human Erythropoietin for Injection Product and Services
- 2.5.4 LG Chem Recombinant Human Erythropoietin for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.5.5 LG Chem Recent Developments/Updates
- 2.6 Daewoong Pharmaceutical
- 2.6.1 Daewoong Pharmaceutical Details
- 2.6.2 Daewoong Pharmaceutical Major Business
- 2.6.3 Daewoong Pharmaceutical Recombinant Human Erythropoietin for Injection Product and Services
- 2.6.4 Daewoong Pharmaceutical Recombinant Human Erythropoietin for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.6.5 Daewoong Pharmaceutical Recent Developments/Updates
- 2.7 Wockhardt
- 2.7.1 Wockhardt Details
- 2.7.2 Wockhardt Major Business
- 2.7.3 Wockhardt Recombinant Human Erythropoietin for Injection Product and Services
- 2.7.4 Wockhardt Recombinant Human Erythropoietin for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.7.5 Wockhardt Recent Developments/Updates
- 2.8 CJ Healthcare
- 2.8.1 CJ Healthcare Details
- 2.8.2 CJ Healthcare Major Business
- 2.8.3 CJ Healthcare Recombinant Human Erythropoietin for Injection Product and Services
- 2.8.4 CJ Healthcare Recombinant Human Erythropoietin for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.8.5 CJ Healthcare Recent Developments/Updates
- 2.9 3SBio
- 2.9.1 3SBio Details
- 2.9.2 3SBio Major Business
- 2.9.3 3SBio Recombinant Human Erythropoietin for Injection Product and Services
- 2.9.4 3SBio Recombinant Human Erythropoietin for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.9.5 3SBio Recent Developments/Updates
- 2.10 Kexing Biopharm
- 2.10.1 Kexing Biopharm Details
- 2.10.2 Kexing Biopharm Major Business
- 2.10.3 Kexing Biopharm Recombinant Human Erythropoietin for Injection Product and Services
- 2.10.4 Kexing Biopharm Recombinant Human Erythropoietin for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.10.5 Kexing Biopharm Recent Developments/Updates
- 2.11 Harbin Pharmaceutical Group
- 2.11.1 Harbin Pharmaceutical Group Details
- 2.11.2 Harbin Pharmaceutical Group Major Business
- 2.11.3 Harbin Pharmaceutical Group Recombinant Human Erythropoietin for Injection Product and Services
- 2.11.4 Harbin Pharmaceutical Group Recombinant Human Erythropoietin for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.11.5 Harbin Pharmaceutical Group Recent Developments/Updates
- 2.12 Beijing Four Rings Bio-Pharmaceutical
- 2.12.1 Beijing Four Rings Bio-Pharmaceutical Details
- 2.12.2 Beijing Four Rings Bio-Pharmaceutical Major Business
- 2.12.3 Beijing Four Rings Bio-Pharmaceutical Recombinant Human Erythropoietin for Injection Product and Services
- 2.12.4 Beijing Four Rings Bio-Pharmaceutical Recombinant Human Erythropoietin for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.12.5 Beijing Four Rings Bio-Pharmaceutical Recent Developments/Updates
3 Competitive Environment: Recombinant Human Erythropoietin for Injection by Manufacturer
- 3.1 Global Recombinant Human Erythropoietin for Injection Sales Quantity by Manufacturer (2018-2023)
- 3.2 Global Recombinant Human Erythropoietin for Injection Revenue by Manufacturer (2018-2023)
- 3.3 Global Recombinant Human Erythropoietin for Injection Average Price by Manufacturer (2018-2023)
- 3.4 Market Share Analysis (2022)
- 3.4.1 Producer Shipments of Recombinant Human Erythropoietin for Injection by Manufacturer Revenue ($MM) and Market Share (%): 2022
- 3.4.2 Top 3 Recombinant Human Erythropoietin for Injection Manufacturer Market Share in 2022
- 3.4.2 Top 6 Recombinant Human Erythropoietin for Injection Manufacturer Market Share in 2022
- 3.5 Recombinant Human Erythropoietin for Injection Market: Overall Company Footprint Analysis
- 3.5.1 Recombinant Human Erythropoietin for Injection Market: Region Footprint
- 3.5.2 Recombinant Human Erythropoietin for Injection Market: Company Product Type Footprint
- 3.5.3 Recombinant Human Erythropoietin for Injection Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global Recombinant Human Erythropoietin for Injection Market Size by Region
- 4.1.1 Global Recombinant Human Erythropoietin for Injection Sales Quantity by Region (2018-2029)
- 4.1.2 Global Recombinant Human Erythropoietin for Injection Consumption Value by Region (2018-2029)
- 4.1.3 Global Recombinant Human Erythropoietin for Injection Average Price by Region (2018-2029)
- 4.2 North America Recombinant Human Erythropoietin for Injection Consumption Value (2018-2029)
- 4.3 Europe Recombinant Human Erythropoietin for Injection Consumption Value (2018-2029)
- 4.4 Asia-Pacific Recombinant Human Erythropoietin for Injection Consumption Value (2018-2029)
- 4.5 South America Recombinant Human Erythropoietin for Injection Consumption Value (2018-2029)
- 4.6 Middle East and Africa Recombinant Human Erythropoietin for Injection Consumption Value (2018-2029)
5 Market Segment by Type
- 5.1 Global Recombinant Human Erythropoietin for Injection Sales Quantity by Type (2018-2029)
- 5.2 Global Recombinant Human Erythropoietin for Injection Consumption Value by Type (2018-2029)
- 5.3 Global Recombinant Human Erythropoietin for Injection Average Price by Type (2018-2029)
6 Market Segment by Application
- 6.1 Global Recombinant Human Erythropoietin for Injection Sales Quantity by Application (2018-2029)
- 6.2 Global Recombinant Human Erythropoietin for Injection Consumption Value by Application (2018-2029)
- 6.3 Global Recombinant Human Erythropoietin for Injection Average Price by Application (2018-2029)
7 North America
- 7.1 North America Recombinant Human Erythropoietin for Injection Sales Quantity by Type (2018-2029)
- 7.2 North America Recombinant Human Erythropoietin for Injection Sales Quantity by Application (2018-2029)
- 7.3 North America Recombinant Human Erythropoietin for Injection Market Size by Country
- 7.3.1 North America Recombinant Human Erythropoietin for Injection Sales Quantity by Country (2018-2029)
- 7.3.2 North America Recombinant Human Erythropoietin for Injection Consumption Value by Country (2018-2029)
- 7.3.3 United States Market Size and Forecast (2018-2029)
- 7.3.4 Canada Market Size and Forecast (2018-2029)
- 7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
- 8.1 Europe Recombinant Human Erythropoietin for Injection Sales Quantity by Type (2018-2029)
- 8.2 Europe Recombinant Human Erythropoietin for Injection Sales Quantity by Application (2018-2029)
- 8.3 Europe Recombinant Human Erythropoietin for Injection Market Size by Country
- 8.3.1 Europe Recombinant Human Erythropoietin for Injection Sales Quantity by Country (2018-2029)
- 8.3.2 Europe Recombinant Human Erythropoietin for Injection Consumption Value by Country (2018-2029)
- 8.3.3 Germany Market Size and Forecast (2018-2029)
- 8.3.4 France Market Size and Forecast (2018-2029)
- 8.3.5 United Kingdom Market Size and Forecast (2018-2029)
- 8.3.6 Russia Market Size and Forecast (2018-2029)
- 8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
- 9.1 Asia-Pacific Recombinant Human Erythropoietin for Injection Sales Quantity by Type (2018-2029)
- 9.2 Asia-Pacific Recombinant Human Erythropoietin for Injection Sales Quantity by Application (2018-2029)
- 9.3 Asia-Pacific Recombinant Human Erythropoietin for Injection Market Size by Region
- 9.3.1 Asia-Pacific Recombinant Human Erythropoietin for Injection Sales Quantity by Region (2018-2029)
- 9.3.2 Asia-Pacific Recombinant Human Erythropoietin for Injection Consumption Value by Region (2018-2029)
- 9.3.3 China Market Size and Forecast (2018-2029)
- 9.3.4 Japan Market Size and Forecast (2018-2029)
- 9.3.5 Korea Market Size and Forecast (2018-2029)
- 9.3.6 India Market Size and Forecast (2018-2029)
- 9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
- 9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
- 10.1 South America Recombinant Human Erythropoietin for Injection Sales Quantity by Type (2018-2029)
- 10.2 South America Recombinant Human Erythropoietin for Injection Sales Quantity by Application (2018-2029)
- 10.3 South America Recombinant Human Erythropoietin for Injection Market Size by Country
- 10.3.1 South America Recombinant Human Erythropoietin for Injection Sales Quantity by Country (2018-2029)
- 10.3.2 South America Recombinant Human Erythropoietin for Injection Consumption Value by Country (2018-2029)
- 10.3.3 Brazil Market Size and Forecast (2018-2029)
- 10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
- 11.1 Middle East & Africa Recombinant Human Erythropoietin for Injection Sales Quantity by Type (2018-2029)
- 11.2 Middle East & Africa Recombinant Human Erythropoietin for Injection Sales Quantity by Application (2018-2029)
- 11.3 Middle East & Africa Recombinant Human Erythropoietin for Injection Market Size by Country
- 11.3.1 Middle East & Africa Recombinant Human Erythropoietin for Injection Sales Quantity by Country (2018-2029)
- 11.3.2 Middle East & Africa Recombinant Human Erythropoietin for Injection Consumption Value by Country (2018-2029)
- 11.3.3 Turkey Market Size and Forecast (2018-2029)
- 11.3.4 Egypt Market Size and Forecast (2018-2029)
- 11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
- 11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
- 12.1 Recombinant Human Erythropoietin for Injection Market Drivers
- 12.2 Recombinant Human Erythropoietin for Injection Market Restraints
- 12.3 Recombinant Human Erythropoietin for Injection Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
- 13.1 Raw Material of Recombinant Human Erythropoietin for Injection and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Recombinant Human Erythropoietin for Injection
- 13.3 Recombinant Human Erythropoietin for Injection Production Process
- 13.4 Recombinant Human Erythropoietin for Injection Industrial Chain
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Recombinant Human Erythropoietin for Injection Typical Distributors
- 14.3 Recombinant Human Erythropoietin for Injection Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Recombinant Human Erythropoietin for Injection. Industry analysis & Market Report on Recombinant Human Erythropoietin for Injection is a syndicated market report, published as Global Recombinant Human Erythropoietin for Injection Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029. It is complete Research Study and Industry Analysis of Recombinant Human Erythropoietin for Injection market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
